Clinical Trials
11 trialsNCT04380337 2025-02-25
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Stanford University
Phase 2 Completed
NCT05081687 2023-10-11
BRAZIL-TNT
Hospital Israelita Albert Einstein
Phase 3 Unknown
NCT05201430 2022-03-04
RCNAC
Fudan University
Phase 3 Recruiting
NCT02217020 2021-04-14
FORTUNE
Sun Yat-sen University
Phase 2 Completed
NCT03484221 2021-04-14
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
China Medical University, China
Phase 2 Unknown
NCT04838496 2021-04-09
MEND-IT
Catharina Ziekenhuis Eindhoven
Phase 2 Not yet recruiting
NCT03443661 2021-02-01
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
ChineseAMS
Phase 2 Completed
NCT03161574 2019-08-08
FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer
Guangxi Medical University
Phase 2 Withdrawn
NCT03975049 2019-06-05
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Not yet recruiting
NCT03671252 2019-01-23
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Sun Yat-sen University
Phase 3 Recruiting
NCT02942563 2018-01-03
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
RenJi Hospital
Phase 2 Unknown